Global Digital Health Market, 2030: Opportunities to Innovation - Focused Start-Ups and Investors
DUBLIN, Sept. 5, 2018 /PRNewswire/ --
The "Digital Health Market: Focus on Digital Therapeutic, Monitoring and Diagnostic Solutions, 2018-2030" report has been added to ResearchAndMarkets.com's offering.
The Digital Health Market: Focus on Digital Therapeutic, Monitoring & Diagnostic Solutions, 2018-2030' report features an extensive study of the current landscape and future outlook of the growing market for digital therapeutics, monitoring and diagnostic solutions that are either commercialized or under development within the healthcare industry. This burgeoning field presently offers a lot of opportunities to innovation focused start-ups and investors.
Digital healthcare, a relatively new concept that emerged only a few years ago, is believed to possess the potential to address the rising concerns related to the growing socio-economic burden. Driven by the demand for self-management approaches, personalized healthcare solutions and customized treatment regimens made available in the home-care setting, digital health companies are presently engaged in developing several innovative solutions for therapeutic, surveillance and diagnostic use.
Various digital therapeutics, through behavioral and psychological interventions, have been designed to have a direct impact on the chronic clinical conditions by providing motivational support and encouraging patients to make better lifestyle choices. Such therapeutics are available in a variety of gaming solutions, standalone software applications or combinations of the aforementioned solutions with personal coaching support, artificial intelligence (AI) support and medical device(s).
A number of digital therapeutics have already been marketed and a significant proportion of such candidate therapies are in R&D phase. In order to introduce such unconventional products into the market, companies have followed multiple approaches, which include both B2B and B2C variants. It is also worth highlighting that certain companies are even attempting to offer reimbursements for their proprietary products by conducting clinical trials in order to establish therapeutic credibility and convince insurance providers and payers.
Significant advancements have also been made towards the development of novel solutions for remote monitoring and diagnosis of chronic disorders. Such solutions have been developed to provide healthcare assistance in real-time through smartphone applications and connected devices. These solutions vary significantly in complexity and range from simple solutions capable of tracking weight loss, blood pressure, body temperature and heart rate to more sophisticated solutions that are equipped to independently conduct blood tests to confirm the presence of a bacterial / viral infection.
One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the market. Based on multiple parameters, such as prices of digital solutions, indication / region specific adoption trends, distribution channels and competitive landscape, we have provided an informed estimate on the likely evolution of digital therapeutics and digital monitoring / diagnostic solutions till 2030.
In order to account for the uncertainties associated with the development of digital therapeutics and novel diagnostic / monitoring solutions and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market's evolution.
Key Topics Covered:
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Digitization in Healthcare Sector
3.2. Next-Generation Healthcare Solutions
3.3. Key Concepts Associated with Digital Health Solutions
3.3.1. Cognitive Behavioral Therapy
3.3.2. Internet of Things
3.3.3. Big Data
3.3.4. Artificial Intelligence
3.3.5. Gamification
3.4. An Overview of Digital Therapeutics
3.4.1. Key Strategic Initiatives
3.4.1.1. Digital Therapeutics Alliance
3.4.1.2. Personal Connected Health Alliance
3.4.1.3. Programs Initiated by The Centers for Disease Control and Prevention
3.4.1.4. HIPAA Act
3.4.1.5. National Health Service Guidelines
3.4.1.6. USFDA Regulations for Digital Therapeutics
3.4.2. Typical Development and Commercialization Pathway for Digital Therapeutics
3.4.2.1. Discovery and Preclinical Phase
3.4.2.2. Clinical Trials and Validation
3.4.2.3. Negotiation with Insurance Providers / Payers
3.4.2.4. Distribution and Marketing
3.4.3. Rising Popularity of Digital Therapeutics
3.5. Remote Digital Monitoring and Diagnosis
4. CURRENT MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Digital Therapeutics: Overall Market Landscape
4.3. Digital Monitoring / Diagnostic Solutions: Overall Market Landscape
5. DIGITAL THERAPEUTICS: COMPANY PROFILES
5.1. Chapter Overview
5.2. 2Morrow
5.3. Akili Interactive
5.4. Canary Health
5.5 Floreo
5.6. Omada Health
5.7. Pear Therapeutics
5.8. Vida Health
5.9. WellDoc
5.10. Wellthy Therapeutics
6. DIGITAL MONITORING / DIAGNOSTIC SOLUTIONS: COMPANY PROFILES
6.1. Chapter Overview
6.2. AliveCor
6.3. BioSerenity
6.4. Cue
6.5. Kinsa
6.6. Voluntis
7. KEY INSIGHTS: PRODUCT COMPETITIVENESS ANALYSIS AND MARKET LANDSCAPE
7.1. Chapter Overview
7.2. Key Therapeutic Areas
7.2.1. Metabolic Disorders
7.2.2. Mental Health Problems
7.2.3. Neurological Disorders
7.2.4. Other Therapeutic Areas
8. DIGITAL THERAPEUTICS: CLINICAL RESEARCH EVIDENCE
8.1. Chapter Overview
8.2. Digital Therapeutics: Clinical Trials Data
8.3. Digital Therapeutics: Clinical Trials Data: Distribution by Therapeutic Areas
8.4. Digital Therapeutics: Clinical End-Points Analysis: Metabolic Disorders
9. FUNDING AND INVESTMENT ANALYSIS
9.1. Chapter Overview
9.2. Types of Funding
9.3. Digital Therapeutics: Funding and Investment Analysis
9.3.1. Analysis by Number of Funding Instances
9.3.2. Analysis by Amount Invested
9.3.3. Analysis by Type of Funding
9.3.4. Most Active Players in terms of Number of Instances
9.3.5. Most Active Players in terms of Amount of Funding
9.3.6. Most Active Investors in terms of Number of Instances
9.4. Digital Monitoring / Diagnostic Solutions: Funding and Investment Analysis
9.4.1. Analysis by Number of Funding Instances
9.4.2. Analysis by Amount Invested
9.4.3. Analysis by Type of Funding
9.4.4. Most Active Players in terms of Number of Instances
9.4.5. Most Active Players in terms of Amount of Funding
9.4.6. Most Active Investors in terms of Number of Instances
10. COLLABORATIONS AND PARTNERSHIPS
10.1. Chapter Overview
10.2. Partnership Models
10.3. Digital Therapeutics and Monitoring / Diagnostic Solutions: Recent Collaborations and Partnerships
10.3.1. Analysis by Year of Partnership
10.3.2. Analysis by Type of Partnership
10.3.3. Analysis by Most Active Players
11. GO-TO-MARKET STRATEGY
11.1. Chapter Overview
11.2. Digital Therapeutic Developers: Marketing Strategies
11.2.1. Participation in Global Events
11.2.2. Marketing on Social Media Platforms
11.2.3. Marketing on Online / Print Media Platforms
11.2.4. Adoption of Different Business Models and Pricing Strategies
11.2.4.1. B2C Business Model
11.2.4.2. B2B Business Model
11.2.4.3. Pricing Strategy
11.2.5. Undertaking Various Promotional Activities
11.3. Concluding Remarks
12. MARKET FORECAST
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Digital Therapeutics Market, 2018-2030
12.4. Global Digital Therapeutics Market: Distribution by Type of Solution
12.5. Global Digital Therapeutics Market: Distribution by Focus of Solution
12.6. Global Digital Therapeutics Market: Distribution by Purpose of Solution
12.7. Global Digital Therapeutics Market: Distribution by Business Model
12.8. Global Digital Therapeutics Market: Distribution by Geography
12.9. Global Digital Therapeutics Market: Distribution by Therapeutic Area
12.10. Global Digital Monitoring / Diagnostic Solutions Market, 2018-2030
12.11. Global Digital Monitoring / Diagnostic Solutions Market: Distribution by Type of Solution
12.12. Global Digital Monitoring / Diagnostic Solutions Market: Distribution by Business Model
12.13. Global Monitoring / Diagnostic Solutions Market: Distribution by Geography
12.14. Global Monitoring / Diagnostic Solutions Market: Distribution by Therapeutic Area
13. FUTURE OF DIGITAL SOLUTIONS FOR CHRONIC DISEASE MANAGEMENT
13.1. Chapter Overview
13.2. Digital Health Solutions: SWOT Analysis
13.2.1. Strengths
13.2.2. Weaknesses
13.2.3. Opportunities
13.3.4. Threats
13.3. Digital Solutions for Chronic Disorders: Future Opportunities
13.3.1. Increasing Focus on Patient Centric Models
13.3.2. Applicability Across a Variety of Disease Indications
13.3.3. Increasing Emphasis on Real-World Evidence in R&D
13.3.4. Advances in IT and Computing Power to Foster Future Innovation
13.3.5. Rising Future Demand for Digital Solutions
13.4. Concluding Remarks
14. INTERVIEW TRANSCRIPTS
14.1. Chapter Overview
14.2. Adam Kaufman, Chief Executive Officer, Canary Health
14.3. Amelie Janson, Communications Manager, Voluntis
14.4. Prayat Shah, Co-founder and Vice President, Partnerships, and Reshma Nayak Vice President, Marketing and Communications, Wellthy Therapeutics
14.5. Stephanie Tilenius, Co-Founder and Chief Executive Officer, Vida Health
14.6. Vijay Ravindran, Chief Executive Officer, Floreo
15. APPENDIX 1: TABULATED DATA
16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
For more information about this report visit https://www.researchandmarkets.com/research/k37wlm/global_digital?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article